As of Jul 06
| +0.47 / +2.21%|
The 10 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a +3.50% increase from the last price of 21.74.
The current consensus among 10 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.